Clinical Trials in Austin

Showing 4281-4300 of 15,205 trials

Long-Term Follow-up Study of ADVM-022 in DME (INFINITY-EXT)

NCT05607810

This is a prospective, observational study designed to evaluate the long-term safety and tolerability of ADVM-022 in participants with diabetic macular edema (DME). Participants who previously participated in the INFINITY parent study and received a single unilateral intravitreal dose of ADVM-022 are eligible for enrollment upon completion of the end of study visit in the parent study.

Diabetic Macular EdemaDiabetic Retinopathy

Adverum Biotechnologies, Inc.22 participantsStarted Aug 2022

Beverly Hills, California, United States • Reno, Nevada, United States • Philadelphia, Pennsylvania, United States +4 more locations

COMPLETEDPhase 2< 1 mile

Phase 2 Study of HL-009 Liposomal Gel to Treat Mild to Moderate Atopic Dermatitis

NCT01568489

The objective of this phase 2 study is to evaluate the safety and efficacy of HL-009 Liposomal Gel in adult patients with mild to moderate atopic dermatitis (AD).

Mild to Moderate Atopic Dermatitis

HanAll BioPharma Co., Ltd.120 participantsStarted Apr 2012

Arlington Heights, Illinois, United States • Fridley, Minnesota, United States • Berlin, New Jersey, United States +4 more locations

COMPLETEDPhase 1/2< 1 mile

A Dose Ranging Study of OPT-302 With Aflibercept for Persistent Diabetic Macular Edema

NCT03397264

A two part, multi-center study consisting of a Phase 1b open label, sequential dose escalation followed by a Phase 2a randomized, double-masked, dose expansion evaluating OPT-302 in combination with aflibercept in participants with persistent central-involved Diabetic Macular Edema.

Diabetic Macular Edema

Opthea Limited153 participantsStarted Jan 2018

Phoenix, Arizona, United States • Bakersfield, California, United States • Beverly Hills, California, United States +50 more locations

Long-Term Follow-up Study of ADVM-022 in DME (INFINITY-EXT)

Phase 2 Study of HL-009 Liposomal Gel to Treat Mild to Moderate Atopic Dermatitis

A Dose Ranging Study of OPT-302 With Aflibercept for Persistent Diabetic Macular Edema

Find Trials by Condition in Austin

A Study of CTX-009 in Combination With Paclitaxel in Adult Patients With Unresectable Advanced, Metastatic or Recurrent Biliary Tract Cancers (COMPANION-002)

Study to Assess PT010 in Adult and Adolescent Participants With Inadequately Controlled Asthma (KALOS)

Ph 2 Study of the Safety and Efficacy of Three HU6 Dose Levels and Placebo in Nonalcoholic Steatohepatitis

Web-Based Physical Activity Intervention in Improving Long Term Health in Children and Adolescents With Cancer

Study to Assess PT010 in Adult and Adolescent Participants With Inadequately Controlled Asthma (LOGOS)

Autologous Adipose-derived Stromal Vascular Fraction for Treatment of Knee Osteoarthritis

Microfragmented Adipose Tissue Compared to Corticosteroid Injection for the Treatment of Knee Osteoarthritis

Exemestane, Letrozole, or Anastrozole in Treating Postmenopausal Women Who Are Undergoing Surgery for Stage II or Stage III Breast Cancer

Delayed Heterologous SARS-CoV-2 Vaccine Dosing (Boost) After Receipt of EUA Vaccines

A Study to Evaluate Rozanolixizumab in Study Participants With Generalized Myasthenia Gravis

A Trial to Learn Whether Regorafenib in Combination With Nivolumab Can Improve Tumor Responses and How Safe it is for Participants With Solid Tumors

Long-term Follow-up Study With Darvadstrocel in the Treatment of Complex Perianal Fistula

FIH Study of RGT-419B Alone and With Endocrine Therapy in HR-Positive, HER2-Negative Advanced/Metastatic Breast Cancer

Massed Prolonged Exposure for PTSD in Substance Use Treatment

Comparative Study of Conventional MR Images With Synthetically Reconstructed MR Images of the Brain

Study of Ad-RTS-hIL-12 + Veledimex in Combination With Cemiplimab in Subjects With Recurrent or Progressive Glioblastoma

A Study to Investigate BGB-3245 (Brimarafenib) With Panitumumab in Participants With Advanced or Metastatic RAS Mutant Colorectal and Pancreatic Ductal Cancers